Hinda Boutrid, MD

Peter Schmidt is a Clinical Assistant Professor specializing in Anesthesiology, Perioperative, and Pain Medicine, affiliated with Stanford Health Care in San Jose, CA. He holds board certifications in both Anesthesiology and Pain Medicine and completed his fellowship in Pain Management at Stanford University. Dr. Schmidt has an extensive educational background, including a medical degree from the University of Colorado School of Medicine and a residency at the University of Virginia Health System. His research contributions focus on postoperative pain management and opioid cessation, with several publications in reputable medical journals. Generated from the website

Melissa Berhow is a Clinical Associate Professor specializing in Anesthesiology, Perioperative, and Pain Medicine, affiliated with Stanford Health Care. She completed her medical education at Yale School of Medicine and underwent her internship and residency at Stanford University Medical Center. As a board-certified anesthesiologist, Dr. Berhow provides expert care in anesthesia and pain management, contributing to the high standards of patient care at Stanford Health Care facilities. Her practice is part of a network of independent nonprofit organizations that collaborate closely with Stanford University while maintaining separate operational structures. Generated from the website

I am a brain tumor neurosurgeon, treating patients with malignant and benign tumors, including gliomas, brain metastases, meningiomas, and schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cerebrospinal fluid-based biomarkers to track brain cancer treatment response, relapse, and neurotoxicity.